EPISODE · Dec 13, 2024 · 19 MIN
#2 - Nicole Bell, Chief Commercial Officer at Curai Health
from Healthcare AI in Review · host Slice of Media, Inc.
Welcome to Healthcare: AI In Review! Our guest:Nicole Bell, Chief Commercial Officer at Curai Health Moderated ByMissy Krasner, Gen AI Investor/Board AdvisorIn this episode, we discussed:Nicole Bell shares her career journey and her work at Curai Health.Curai Health’s AI-driven care model supports longitudinal primary care.Transitioning from machine learning to generative AI for patient intake and efficiency.Collaborations with Priority Health and Tufts Medicine to improve care access.Learn more about Guest Company!Curai Health: https://www.curaihealth.com/'Healthcare: AI In Review' is part the Slice of Healthcare NetworkSlice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
What this episode covers
Welcome to Healthcare: AI In Review! Our guest:Nicole Bell, Chief Commercial Officer at Curai Health Moderated ByMissy Krasner, Gen AI Investor/Board AdvisorIn this episode, we discussed:Nicole Bell shares her career journey and her work at Curai Health.Curai Health’s AI-driven care model supports longitudinal primary care.Transitioning from machine learning to generative AI for patient intake and efficiency.Collaborations with Priority Health and Tufts Medicine to improve care access.Learn more about Guest Company!Curai Health: https://www.curaihealth.com/'Healthcare: AI In Review' is part the Slice of Healthcare NetworkSlice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
NOW PLAYING
#2 - Nicole Bell, Chief Commercial Officer at Curai Health
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m